Led by Dr. Frederick K. Nahm — a fellowship-trained, board-certified neurologist providing clinicaloversight, consulting, and research leadership.
Neurocare Health is a neuroscience-focused company dedicated to advancing the quality, safety, and scientific rigor of clinical research and neurological innovation. Led by Frederick Nahm, MD, PhD, a board-certified, fellowship-trained neurologist, the company provides expert clinical oversight for clinical trials, neuroscience ventures, and emerging technologies in neurology.
Operating through a collaborative model, Neurocare Health partners with a trusted network of neurologists, neuroscientists, clinical researchers, and regulatory specialists. Together, we support sponsors, CROs, and innovative health-technology companies with leadership across the full lifecycle of neuroscience development—ranging from protocol design and medical monitoring to endpoint strategy, safety oversight, and operational feasibility.
Grounded in clinical excellence and scientific integrity, Neurocare Health brings a uniquely integrated approach to modern neuroscience research, ensuring that each project benefits from deep subject-matter expertise, real-world clinical insight, and unwavering commitment to participant safety and data reliability.
Lead Neurologist, Managing Partner
Dr. Nahm is a board-certified neurologist with extensive experience in clinical research, medical monitoring, and bioethics. He provides expert oversight in clinical trials, neuromonitoring, and consulting for biotechnology and pharmaceutical organizations.
His clinical focus includes Cognitive Disorders, Stroke, Neuromuscular Disorders, Traumatic Brain Injury, and Neuropathy.
Trained at world-leading medical institutions, combining deep scientific knowledge with real-world clinical experience.
Learn more about Neurocare Health’s leadership in clinical
research, medical monitoring, and consulting.
